Neurogene Inc.
USD36.66
-0.68 (-1.82%)
CEO
Rachel L. McMinn
IPO Date
2014-03-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$36.99
Prev. Close
$37.34
Day Low
$35.23
Day High
$37.59
52W Low
$15.93
52W High
$43.66
Market Cap
$0.58B
Volume
0.07M
| 4,200 |
| $36.13 |
| 2 Jul 2026 | Cvijic Christine Mikail | director, officer: President and CFO | S-Sale | Disposed | 739 | $34.06 |
| 2 Jul 2026 | Cvijic Christine Mikail | director, officer: President and CFO | S-Sale | Disposed | 2,531 | $34.58 |
| 2 Jul 2026 | Cvijic Christine Mikail | director, officer: President and CFO | S-Sale | Disposed | 1,530 | $35.23 |
| 16 Jun 2026 | Woods Keith | director | A-Award | Acquired | 15,400 | $32.30 |
| 16 Jun 2026 | Woods Keith | director | A-Award | Acquired | 7,700 | $42.59 |
| 16 Jun 2026 | Woods Keith | director | A-Award | Acquired | 12,050 | $20.40 |
| 16 Jun 2026 | Woods Keith | director: | Disposed | 0 | $0.00 |
| 8 May 2026 | Cvijic Christine Mikail | director, officer: President and CFO | S-Sale | Disposed | 4,800 | $30.07 |